Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $421.00

Intuitive Surgical (NASDAQ:ISRG) had its price target raised by BTIG Research from $412.00 to $421.00 in a report issued on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

ISRG has been the topic of several other research reports. Citigroup upped their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a buy rating in a report on Wednesday, April 3rd. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an overweight rating in a report on Friday, January 19th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a buy rating in a research report on Monday, April 8th. Raymond James boosted their price objective on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an outperform rating in a research report on Thursday, January 25th. Finally, Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a hold rating in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average target price of $396.17.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $366.34 on Friday. Intuitive Surgical has a 12-month low of $254.85 and a 12-month high of $403.76. The company has a market capitalization of $129.85 billion, a PE ratio of 66.13, a price-to-earnings-growth ratio of 5.78 and a beta of 1.36. The firm’s 50-day moving average is $386.84 and its two-hundred day moving average is $343.10.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 13.27%. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical will post 4.93 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at $9,373,093.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the sale, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,318 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the sale, the executive vice president now owns 189 shares of the company’s stock, valued at $69,958.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 248,418 shares of company stock valued at $95,927,097. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors have recently bought and sold shares of ISRG. OFI Invest Asset Management purchased a new stake in Intuitive Surgical during the third quarter worth approximately $25,000. Baystate Wealth Management LLC boosted its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC boosted its stake in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC purchased a new position in shares of Intuitive Surgical in the third quarter valued at $28,000. Finally, Able Wealth Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $28,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.